We and others have previously reported that biallelic expression of the IGF2 gene, also known as loss of imprinting (LOI), usually accompanying the overexpression of IGF2, occurs in 40% to 50% of tumors, including CRC, and is thought to be an early event in carcinogenesis [3–8]. Here, IGF2 is linked to colorectal carcinoma.